GlobalData | PharmaTrends
The Pharma Trends research provides a comparative analysis of global pharmaceutical innovation, examining R&D Investment, Clinical Trial Transformation, Financing Evolution, and Cross-Border Deal Activity. The studies reveal fundamental shifts in the geographic distribution of pharmaceutical development, including where trials are conducted, completion timelines, cost structures, and licensing deal flows between markets. This research illuminates how operational efficiencies, regulatory reforms, and infrastructure capabilities are reshaping the international pharmaceutical landscape and rebalancing global innovation dynamics.
Clinical Trials Worldwide Landscape
Research examining R&D Investment & Innovation, Clinical Trial Transformation, Financing Evolution, and Cross-Border Deal Activity reveals a fundamental shift in global pharmaceutical development. China has become a leading clinical trial destination, hosting 30% of global innovative drug trials in 2024, converging on the US number at 33%. This transformation results from rapid patient recruitment, streamlined regulations, and extensive clinical infrastructure, fundamentally reshaping the international pharmaceutical landscape.
